Physician profile

Cindy Sturt

Vascular Surgery · Livingston, NJ

NPI 1073838173

$16,714.27

in general payments reported to CMS, 2019-2025

30 companies · $1,713 in 2025

The $1,713 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,498.19
Travel and Lodging$2,581.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
W. L. Gore & Associates, INC. $5,354.54 2019-2025 Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis
Inari Medical, INC. $1,510.95 2019-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Silk Road Medical, INC. $1,487.48 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Medtronic, INC. $1,261.10 2021-2025 Hawkone, In.Pact Admiral, Endurant Iis
Cook Medical LLC $1,131.49 2019-2025 Zenith Spiral-Z, Zenith Alpha, Cook
Cvrx, INC. $804.48 2023-2025 Barostim Neo System
Penumbra, INC. $667.53 2019-2025 Indigo System, Ruby Coil
Boston Scientific Corporation $556.95 2021-2025 Enroute Transcarotid Neuroprotection System, General - Non-Vascular Intervention, Eluvia
Medtronic Vascular, INC. $487.91 2019
Endologix LLC $412.14 2019-2022
Limflow INC. $312.04 2023 Limflow System
Bolton Medical INC $299.85 2022-2025 Relay Thoracic Stent-Graft With Plus Delivery System
Bard Peripheral Vascular, INC. $291.92 2020-2024 Venclose Maven Catheter, Set Aspirex S 10f 110cm
Lemaitre Vascular, INC. $268.67 2022-2025 Restoreflow, Artegraft Vascular Graft, Xenosure Biologic Patch
Cardiovascular Systems INC. $243.07 2019-2022
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Tactile Systems Technology INC $236.51 2023-2024 Entre Plus, Flexitouch Plus
Convatec INC. $235.87 2024
Acera Surgical, INC. $203.84 2025 Restrata Wound Matrix
Angiodynamics, INC. $185.55 2024 Auryon Laser System 100-120 Vac
Stryker Corporation $158.48 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever
Ge Healthcare $139.00 2019
Ekos Corporation $106.74 2019
Laminate Medical Technologies INC. $105.50 2025 Vasq
Kci USA, INC. $91.83 2019
Janssen Pharmaceuticals, INC $51.20 2019-2021
Baxter Healthcare $27.18 2024 Renal - Pd
Argon Medical Devices, INC. $25.86 2024 Retrieval Kit
Kerecis Limited $25.79 2022
Abbott Laboratories $16.17 2025 Diamondback Peripheral
Amgen INC. $14.63 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cindy Sturt

$16,714.27

in general payments reported 2019-2025

Years
2019-2025
Top company
W. L. Gore & Associates, INC.
Context
The $1,713 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/230541/cindy-sturt

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.